These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7464561

  • 1. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR, Grundy SM.
    Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
    [Abstract] [Full Text] [Related]

  • 2. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB, Probstfield JL, Crow LO, Isaacson SO.
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [Abstract] [Full Text] [Related]

  • 3. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB, Bell C, Olson L.
    Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH, Smith FR, Berns L, Eder HA, Goodman DS.
    Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
    [Abstract] [Full Text] [Related]

  • 5. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
    Hoogwerf BJ, Peters JR, Frantz ID, Hunninghake DB.
    Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ, Linden CV, O'Connell MJ, Heilman J.
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [Abstract] [Full Text] [Related]

  • 7. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA, Heimann KW.
    S Afr Med J; 1975 Jul 19; 49(31):1252-6. PubMed ID: 168650
    [Abstract] [Full Text] [Related]

  • 8. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG, Haft GK, Juliano J.
    Atherosclerosis; 1976 Jul 19; 23(3):413-27. PubMed ID: 178325
    [Abstract] [Full Text] [Related]

  • 9. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
    Schlierf G, Mrozik K, Heuck CC, Middelhoff G, Oster P, Riesen W, Schellenberg B.
    Atherosclerosis; 1982 Jan 19; 41(1):133-8. PubMed ID: 7073790
    [Abstract] [Full Text] [Related]

  • 10. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
    Lithell H, Vessby B, Boberg J, Hellsing K.
    Atherosclerosis; 1980 Oct 19; 37(2):175-86. PubMed ID: 7000089
    [Abstract] [Full Text] [Related]

  • 11. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL, Schonfeld G, Weidman SW.
    J Lab Clin Med; 1976 Dec 19; 88(6):1008-18. PubMed ID: 186544
    [Abstract] [Full Text] [Related]

  • 12. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J.
    Circulation; 1989 Jan 19; 79(1):16-28. PubMed ID: 2642754
    [Abstract] [Full Text] [Related]

  • 13. Plasma and lipoprotein lipid responses to four hypolipid drugs.
    Hazzard WR, Wahl PW, Gagne C, Applebaum-Bowden D, Warnick GR, Albers JJ.
    Lipids; 1984 Feb 19; 19(2):73-9. PubMed ID: 6708754
    [Abstract] [Full Text] [Related]

  • 14. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
    Weisweiler P.
    Metabolism; 1989 Mar 19; 38(3):271-4. PubMed ID: 2918846
    [Abstract] [Full Text] [Related]

  • 15. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C, Desager JP.
    Clin Pharmacol Ther; 1976 Sep 19; 20(3):310-4. PubMed ID: 182429
    [Abstract] [Full Text] [Related]

  • 16. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
    Kane JP, Malloy MJ, Tun P, Phillips NR, Freedman DD, Williams ML, Rowe JS, Havel RJ.
    N Engl J Med; 1981 Jan 29; 304(5):251-8. PubMed ID: 7003391
    [Abstract] [Full Text] [Related]

  • 17. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
    Weisweiler P, Merk W, Jacob B, Schwandt P.
    Eur J Clin Pharmacol; 1986 Jan 29; 30(2):191-4. PubMed ID: 3709644
    [Abstract] [Full Text] [Related]

  • 18. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
    Glueck CJ, Fallat RW, Mellies M, Tsang RC.
    Pediatrics; 1976 Jan 29; 57(1):68-74. PubMed ID: 174057
    [Abstract] [Full Text] [Related]

  • 19. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
    Ojala JP, Helve E, Karjalainen K, Tarkkanen A, Tikkanen MJ.
    Atherosclerosis; 1990 May 29; 82(1-2):85-95. PubMed ID: 2360923
    [Abstract] [Full Text] [Related]

  • 20. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation.
    Briones ER, Steiger D, Palumbo PJ, Kottke BA.
    Mayo Clin Proc; 1984 Apr 29; 59(4):251-7. PubMed ID: 6708603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.